Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer's disease Braak stages: a quantitative study in humans
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Clarifying the mechanisms connecting NFT neurotoxicity to neuronal dysfunction in humans are likely to be pivotal for developing effective treatments for Alzheimer’s disease. To model the temporal progression of AD in humans, we used a collection of brains with controls and individuals from each Braak stage to quantitatively investigate the correlation between intraneuronal caspase activation or macroautophagy markers, NFT burden and neuronal loss, in the dorsal raphe and locus coeruleus, the earliest vulnerable areas to NFT accumulation. We fit linear regressions with each count as outcomes, with Braak score and age as the predictors. In progressive Braak stages, intraneuronal aCasp-6 positivity increases both alone and overlapping with neurofibrillary tangles (NFT). Likewise, the proportion of NFT bearing neurons showing autophagosomes increases. Overall, caspases may be involved in upstream cascades in AD, and are associated with higher NFTs. Macroautophagy changes correlate with increasing NFT burden from early AD stages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882 · cited 1×
“Defective clearance of processed tau by the autophagy-lysosome system mediates tau aggregation and AD-like pathology in animal models of AD (Hara et al., 2006, Komatsu et al., 2006, Pickford et al., 2008).”
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894 · cited 1×
“AD pathology was staged according to the new NIA-AA guidelines (Montine et al., 2012).”
Autophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583 · cited 2×
“The autophagy-lysosome pathway is one of two major systems responsible for degrading the cellular material and misfolded proteins, the other being the ubiquitin-proteasome system (Choi et al., 2013, Goldberg, 2003).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“…that neuronal and synaptic loss are the best predictors of cognitive decline, (Andrade-Moraes et al., 2013, Arendt, 2009, Coleman et al., 2004, DeKosky and Scheff, 1990, Giannakopoulos et al., 2009, Terry et al., 1991),therefore, interventions targeting pathways involved in AD-related…”
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230 · cited 1×
“…major lysosomal degrading pathway, cytoplasmic cargo is sequestered within autophagosomes, identified by the well-established membrane marker LC3 that regulates the autophagosome formation and remains linked to the mature autophagosome membrane M AN US CR IP T AC CE PT ED (Klionsky et al., 2008).”
Self-citationStages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194 · cited 1×
“…cortical areas only (BB 1 to 6), and revisited in 2011 to include brainstem structures in which NFT formation precedes cortical NFTs (BB 0 a-c) (Braak et al., 2011, Grinberg et al., 2009), is the highly reproducible both in autopsy as in longitudinal tau PET imaging studies (Scholl et al.,…”
Protein degradation and protection against misfolded or damaged proteins.
Goldberg, A. L. (2003) · Nature · doi:10.1038/nature02263 · Cited by 2,088 · cited 1×
“The autophagy-lysosome pathway is one of two major systems responsible for degrading the cellular material and misfolded proteins, the other being the ubiquitin-proteasome system (Choi et al., 2013, Goldberg, 2003).”
The role of autophagy in neurodegenerative disease
Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059
Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
Self-citationNeuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Old, new and emerging functions of caspases
Shalini, S., Dorstyn, L., Dawar, S., & Kumar, S. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.216 · Cited by 1,267 · cited 2×
“For a thorough review of caspases and their role in neurodegenerative diseases, please see Shalini et al. 2015 (Shalini et al., 2015), LeBlanc 2013 (LeBlanc, 2013) and Graham et al. 2011 (Graham et al., 2011).”
PET Imaging of Tau Deposition in the Aging Human Brain
Schöll, M., Lockhart, S. N., Schonhaut, D. R., O’Neil, J. P., Janabi, M., Ossenkoppele, R., Baker, S. L., Vogel, J. W., Faria, J., Schwimmer, H. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.028 · Cited by 1,214 · cited 1×
“…NFTs (BB 0 a-c) (Braak et al., 2011, Grinberg et al., 2009), is the highly reproducible both in autopsy as in longitudinal tau PET imaging studies (Scholl et al., 2016), suggesting that NFT formation is involved in processes culminating in neuronal death (Gomez-Isla et al., 1997, Iqbal et al.,…”
Lee, J.-H., Yu, W. H., Kumar, A., Lee, S., Mohan, P. S., Peterhoff, C. M., Wolfe, D. M., Martinez-Vicente, M., Massey, A. C., Sovak, G., et al. (2010) · Cell · doi:10.1016/j.cell.2010.05.008 · Cited by 1,212
Self-citationMultiplexed ion beam imaging of human breast tumors
Angelo, M., Bendall, S. C., Finck, R., Hale, M. B., Hitzman, C., Borowsky, A. D., Levenson, R. M., Lowe, J. B., Liu, S. D., Zhao, S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3488 · Cited by 1,108
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
Mechanisms of tau-induced neurodegeneration
Iqbal, K., Liu, F., Gong, C.-X., Alonso, A. D. C., & Grundke-Iqbal, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0486-3 · Cited by 628
Caspase activation precedes and leads to tangles
de Calignon, A., Fox, L. M., Pitstick, R., Carlson, G. A., Bacskai, B. J., Spires-Jones, T. L., & Hyman, B. T. (2010) · Nature · doi:10.1038/nature08890 · Cited by 517
Synaptic degeneration in Alzheimer's disease
Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517 · cited 1×
“…independent studies demonstrated that neuronal and synaptic loss are the best predictors of cognitive decline, (Andrade-Moraes et al., 2013, Arendt, 2009, Coleman et al., 2004, DeKosky and Scheff, 1990, Giannakopoulos et al., 2009, Terry et al., 1991),therefore, interventions targeting…”
Theofilas, P., Ehrenberg, A. J., Dunlop, S., Di Lorenzo Alho, A. T., Nguy, A., Leite, R. E. P., Rodriguez, R. D., Mejia, M. B., Suemoto, C. K., Ferretti-Rebustini, R. E. D. L., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.2362 · Cited by 416
Self-citationGrudzien, A., Shaw, P., Weintraub, S., Bigio, E., Mash, D. C., & Mesulam, M. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.007 · Cited by 396 · cited 1×
“…earliest vulnerability to accumulate tau cytoskeletal pathology in AD, prior to any cortical areas (Ehrenberg et al., 2017, Grinberg et al., 2009, Grudzien et al., 2007, Stratmann et al., 2015, Theofilas et al., 2017, Tomlinson et al., 1981) and degenerate progressively with AD increasing…”
The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
Ricciarelli, R., & Fedele, E. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170116143743 · Cited by 380
Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy
Schaeffer, V., Lavenir, I., Ozcelik, S., Tolnay, M., Winkler, D. T., & Goedert, M. (2012) · Brain · doi:10.1093/brain/aws143 · Cited by 343 · cited 1×
“Moreover, pharmacological induction of autophagy in tauopathy mouse models promoted tau clearance and was associated with reduced LC3 positivity, tau hyperphosphorylation, and improved neuronal survival (Ozcelik et al., 2013, Schaeffer et al., 2012).”
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias
Coleman, P., Federoff, H., & Kurlan, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140626.48118.0a · Cited by 314
Guo, H., Albrecht, S., Bourdeau, M., Petzke, T., Bergeron, C., & LeBlanc, A. C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63317-2 · Cited by 287 · cited 3×
“…caspase (Casp)-dependent and autophagy pathways have been implicated in AD pathophysiology, (Cotman and Su, 1996, Cotman et al., 2005, de Calignon et al., 2010, Dickson, 2004, Guo et al., 2004, LeBlanc et al., 2014, Martinez-Vicente and Cuervo, 2007, Piras et al., 2016, Rohn and Head, 2008).”
Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice.
Ozcelik, S., Fraser, G., Castets, P., Schaeffer, V., Skachokova, Z., Breu, K., Clavaguera, F., Sinnreich, M., Kappos, L., Goedert, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062459 · Cited by 226
The Role of Caspase Cleavage of Tau in Alzheimer Disease Neuropathology
Cotman, C. W., Poon, W. W., Rissman, R. A., & Blurton-Jones, M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.104 · Cited by 199
Brazilian Aging Brain Study Group, Grinberg, L. T., de Lucena Ferretti, R. E., Farfel, J. M., Leite, R., Pasqualucci, C. A., Rosemberg, S., Nitrini, R., Saldiva, P. H. N., & Jacob Filho, W. (2007) · Cell and Tissue Banking · doi:10.1007/s10561-006-9022-z · Cited by 169 · cited 5×
“We thank the patients and their families for their invaluable contribution to brain aging neurodegenerative disease research, and the staff of the Sao Paulo Autopsy Service and BBBABSG for technical support.”
InfluentialSelf-citationMacroautophagy deficiency mediates age-dependent neurodegeneration through a phospho-tau pathway
Inoue, K., Rispoli, J., Kaphzan, H., Klann, E., Chen, E. I., Kim, J., Komatsu, M., & Abeliovich, A. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-48 · Cited by 168
Hardy, J. (2017) · The FEBS Journal · doi:10.1111/febs.14004 · Cited by 153 · cited 1×
“…dominant AD cases have been linked to mutations in genes involved with amyloid precursor protein (APP) processing, the conventional view on AD pathogenesis places β-amyloid deposition as a central etiological event driving a cascade of pathological events resulting in neuronal loss (Hardy, 2017).”
Pathological Substrates of Cognitive Decline in Alzheimer’s Disease
Giannakopoulos, P., Kövari, E., Gold, G., von Gunten, A., Hof, P. R., & Bouras, C. (2009) · Frontiers of Neurology and Neuroscience · doi:10.1159/000197881 · Cited by 101 · cited 2×
“On the other hand, the spread of NFTs through neuronal networks, best represented by Braak staging system (BB)(Braak and Braak, 1991), has a strong correlation to neuronal loss and cognitive decline (Giannakopoulos et al., 2009, Suemoto et al., 2017).”
Uribe, V., Wong, B. K. Y., Graham, R. K., Cusack, C. L., Skotte, N. H., Pouladi, M. A., Xie, Y., Feinberg, K., Ou, Y., Ouyang, Y., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds005 · Cited by 78
Ramcharitar, J., Albrecht, S., Afonso, V. M., Kaushal, V., Bennett, D. A., & LeBlanc, A. C. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182a0a39f · Cited by 47
Cited by
Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases
Chi, H., Chang, H.-Y., & Sang, T.-K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103082 · Cited by 412
“Clinical studies have shown a strong correlation between NFT accumulation and the progression of AD [71,75,76].”
BackgroundAn effective multimodal image fusion method using MRI and PET for Alzheimer’s disease diagnosis
Song, J., Zheng, J., Li, P., Lu, X., Zhu, G., & Shen, P. (2021) · Frontiers in Digital Health · doi:10.3389/fdgth.2021.637386 · Cited by 178
Cholesterol and Alzheimer’s Disease Risk: A Meta-Meta-Analysis
Sáiz-Vazquez, O., Puente-Martínez, A., Ubillos-Landa, S., Pacheco-Bonrostro, J., & Santabárbara, J. (2020) · Brain Sciences · doi:10.3390/brainsci10060386 · Cited by 135
Contrastive Learning for Prediction of Alzheimer’s Disease Using Brain 18F-FDG PET
Chen, Y., Wang, H., Zhang, G., Liu, X., Huang, W., Han, X., Li, X., Martin, M., & Tao, L. (2023) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2022.3231905 · Cited by 36
Sonic hedgehog signalling pathway contributes in age-related disorders and Alzheimer’s disease
Parashar, A., jha, D., Mehta, V., Chauhan, B., Ghosh, P., Deb, P. K., Jaiswal, M., & Prajapati, S. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102271 · Cited by 28
Metadata
- Authors
- Theofilas, P., Ehrenberg, A. J., Nguy, A., Thackrey, J. M., Dunlop, S., Mejia, M. B., Alho, A. T., Paraizo Leite, R. E., Rodriguez, R. D., Suemoto, C. K., Nascimento, C. F., Chin, M., Medina-Cleghorn, D., Cuervo, A. M., Arkin, M., Seeley, W. W., Miller, B. L., Nitrini, R., Pasqualucci, C. A., Filho, W. J., Rueb, U., Neuhaus, J., Heinsen, H., & Grinberg, L. T.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 61
- Pages
- 1-12
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2755335783
- Cited by
- 134
- References
- 37
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.